Author

Jason Tay

Observed names: J Tay, J. TAY, J. Tay, Tay, Jason

Observed institutions: Alberta Health Services, Memorial University of Newfoundland, University of Ottawa, University of Calgary, Ottawa Hospital, Ottawa Hospital Research Institute, Arthur J.E. Child Comprehensive Cancer Centre, Canadian Blood Services

ORCID: 0000-0002-5969-9755

Observed ORCID: 0000-0002-5969-9755

OpenAlex ID: A5043652802

A Systematic Review of Preclinical Studies on the Therapeutic Potential of Mesenchymal Stromal Cell-Derived Microvesicles

2014 · Celine Akyurekli, Yevgeniya Le, et al. · Stem Cell Reviews and Reports · 285

Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta‐analysis

2011 · M. CARRIER, G. LE GAL, et al. · Journal of Thrombosis and Haemostasis · 195

PDF

Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic Stem Cell Transplantation

2007 · Jason Tay, Alan Tinmouth, et al. · Transplantation and Cellular Therapy · 127

Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients

2012 · Andrew Aw, Marc Carrier, et al. · Thrombosis Research · 111

Salvage Second Hematopoietic Cell Transplantation in Myeloma

2013 · Laura C. Michaelis, Ayman Saad, et al. · Transplantation and Cellular Therapy · 108

PDF

Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation

2016 · Adam Bryant, Harold Atkins, et al. · JAMA Neurology · 104

PDF

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells

2016 · Amina Kariminia, Shernan G. Holtan, et al. · Blood · 94

Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time

2017 · S K Kumar, A Dispenzieri, et al. · Leukemia · 92

Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation

2014 · Manish Sharma, Mei-Jie Zhang, et al. · Transplantation and Cellular Therapy · 83

PDF

Systematic Review of Randomized Controlled Trials of Hematopoietic Stem Cell Mobilization Strategies for Autologous Transplantation for Hematologic Malignancies

2012 · Dawn Sheppard, Christopher Bredeson, et al. · Transplantation and Cellular Therapy · 80

Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma

2020 · Pashna N. Munshi, David Vesole, et al. · Cancer · 76

The Influence of Social Support on Hematopoietic Stem Cell Transplantation Survival: A Systematic Review of Literature

2013 · Sara Beattie, Sophie Lebel, et al. · PLoS ONE · 65

PDF

Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial

2020 · Jason Tay, David S. Allan, et al. · Journal of Clinical Oncology · 64

PDF

Utility of Comorbidity Assessment in Predicting Transplantation-Related Toxicity Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

2008 · Laura Labonté, Tariq Iqbal, et al. · Transplantation and Cellular Therapy · 55

PDF

Noninfectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation: Practical Approach to Imaging Diagnosis

2014 · Elena Peña, Carolina A. Souza, et al. · Radiographics · 54

New Cancers after Autotransplantations for Multiple Myeloma

2014 · Anuj Mahindra, Girindra Raval, et al. · Transplantation and Cellular Therapy · 47

PDF

Autologous Stem Cell Transplantation for Stiff Person Syndrome

2014 · Sheilagh Sanders, Christopher Bredeson, et al. · JAMA Neurology · 47

Is Cytomegalovirus Testing of Blood Products Still Needed for Hematopoietic Stem Cell Transplant Recipients in the Era of Universal Leukoreduction?

2013 · Natasha Kekre, Melanie Tokessy, et al. · Transplantation and Cellular Therapy · 45

Revised International Staging System Applied to Real World Multiple Myeloma Patients

2016 · Victor H. Jimenez-Zepeda, Peter Duggan, et al. · Clinical Lymphoma Myeloma & Leukemia · 42

Transplantation of Umbilical Cord Blood–Derived Cells for Novel Indications in Regenerative Therapy or Immune Modulation: A Scoping Review of Clinical Studies

2013 · Marco A.J. Iafolla, Jason Tay, et al. · Transplantation and Cellular Therapy · 42

Post-Transplant Outcomes in High-Risk Compared with Non–High-Risk Multiple Myeloma: A CIBMTR Analysis

2016 · Emma C. Scott, Parameswaran Hari, et al. · Transplantation and Cellular Therapy · 41

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation

2015 · G L Uy, L J Costa, et al. · Bone Marrow Transplantation · 39

Thromboprophylaxis for catheter‐related thrombosis in patients with cancer: a systematic review of the randomized, controlled trials

2007 · M. CARRIER, J. TAY, et al. · Journal of Thrombosis and Haemostasis · 34

Acquired Factor XIII Inhibitor in Hospitalized and Perioperative Patients: A Systematic Review of Case Reports and Case Series

2016 · Kira J. Tone, Tyler E. James, et al. · Transfusion Medicine Reviews · 32

Transfusion of red cells in hematopoietic stem cell transplantation (TRIST): study protocol for a randomized controlled trial

2011 · Jason Tay, Alan Tinmouth, et al. · Trials · 32

PDF

Works count: 174

Citation count: 2,786

H-index: 27

I10-index: 58